Adragos' Mission
Our commitment to patients and customers is to keep pharmaceuticals:
Accessible
Global distribution
Available
Reliable supply
Affordable
Competitive prices
Impeccable
Highest quality standards
Four sites
Across France, Germany, Greece and Japan
>700
Highly skilled employees
Double-digit
Year-on-year growth
Global Reach, Local Expertise
Our sites in Europe and Asia present strategic locations that provide access into the major mature pharmaceutical markets.
Leverage our extensive and expanding network, led by seasoned professionals, to gain an edge both regionally and locally.
Why Partner with Us?
Quality and Customer Centricity
We ensure strict criteria is met and prioritize consistency in our service quality.
Data-Driven CDMO
Data matters! That’s why we are investing in a data-driven roadmap at Adragos Pharma to ensure that our offerings match the industry's needs.
Comprehensive Service Offerings
With our comprehensive and ever-expanding range of services at attractive locations, we are able to meet the needs of our global customers.
ESG Focus
We are committed to operating with sustainable and ethical business practices that take into account environmental impact, social responsibility and strong corporate governance.
Exciting times are ahead of us!
This is going to be great! But we can’t do it alone! Join us – we are always looking for great talent.
What's new?
Join Adragos Pharma at CPHI Barcelona 2023 – October 24-26
Dear Valued Partners and Industry Enthusiasts, We are thrilled to announce that the Adragos Pharma team will be participating in one of the pharmaceutical industry’s
Adragos Pharma Announces Divestiture of Toride Pharma K.K. and Toride Asset Trading Co. Ltd.
Munich, Germany / Tokyo, Japan, June 15, 2023 — Adragos Pharma GmbH, a global leader in pharmaceutical manufacturing, announced today that it has completed the
Successful transaction: Adragos Pharma has officially taken over Clinigen’s development unit, Lamda Laboratories near Athens, Greece
Adragos on a growth path: Three locations in Europe and five globally Acquisition strengthens Adragos’ end-to-end integrated pharmaceutical product development service offering Agreement on further
